Inactive Instrument
Foundation Medicine Inc Stock
Stocks
US3504651007
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Malarek
CEO | Chief Executive Officer | - | 01/11/2023 |
Dominique Schutz
DFI | Director of Finance/CFO | - | 01/01/2022 |
Michael Kling
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Jones
BRD | Director/Board Member | 69 | 08/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 0 | ||
| +1.09% | +5.26% | +4.44% | +26.03% | 51.61B | ||
| -1.07% | +2.82% | +474.18% | +601.24% | 44.89B | ||
| +1.47% | +9.79% | +40.15% | +21.21% | 42.77B | ||
| +1.44% | +7.77% | +19.27% | +90.94% | 42.58B | ||
| -0.93% | -4.33% | +17.87% | +51.96% | 31.82B | ||
| +1.32% | +7.30% | +36.93% | +152.36% | 17.33B | ||
| -0.60% | +1.93% | - | - | 16.63B | ||
| +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | ||
| +1.28% | +5.41% | +91.01% | +46.93% | 14.09B | ||
| Average | +0.40% | +4.43% | +86.37% | +128.27% | 30.72B | |
| Weighted average by Cap. | +0.49% | +4.72% | +102.57% | +148.52% |
















